Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Bafilomycin C1: Designing Smarter Flux Assays
2026-08-16
Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that can turn lysosomal acidification into a measurable experimental variable. This guide connects V-ATPase biology with high-content phenotyping, autophagy assay design, and the deep-learning strategy used in iPSC-cardiomyocyte screening.
-
Vincristine Sulfate: Assay Design Through Mechanistic Lenses
2026-08-15
Vincristine sulfate is a powerful tool for cancer research, but its microtubule mechanism requires careful separation of cytotoxicity from downstream inflammatory signals. This article applies a systematic-review framework to improve assay interpretation, controls, and translational relevance.
-
ML365, NLRP3, and Cognitive Impairment in Aged Mice
2026-08-14
A 2024 Brain Research study reports that ML365 pretreatment reduced postoperative cognitive impairment in aged mice after exploratory laparotomy, alongside lower hippocampal NLRP3 inflammasome signaling, tissue injury, and systemic oxidative stress. The work connects two-pore potassium-channel pharmacology with hippocampal neuroinflammation, while also leaving open whether the observed effects are specifically mediated by TASK1 inhibition.
-
SR 11302 and the Translational Logic of AP-1 Blockade
2026-08-14
SR 11302 offers a retinoid-independent approach to studying AP-1-driven tumor biology. By connecting its selective antiproliferative profile with macrophage and TLR4 findings from a colitis-associated colorectal cancer study, researchers can design more discriminating experiments while avoiding premature claims about therapeutic efficacy.
-
Wortmannin: PI3K Inhibitor Mechanism & Use
2026-08-13
Wortmannin is a selective and irreversible PI3K inhibitor used to interrogate PI3K/Akt/mTOR signaling, autophagy, apoptosis, and cancer biology. Product data report nanomolar PI3K potency, higher micromolar MLCK activity, DMSO solubility, and storage at −20°C.
-
HRP Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-13
The HRP Rabbit Anti-Goat IgG (H+L) Antibody is a horseradish peroxidase conjugated secondary antibody for immunodetection of goat primary antibodies. Product-listed formulation, storage conditions, and application-specific dilution ranges support reproducible ELISA, western blot, dot blot, and tissue-staining workflows.
-
Y-27632: From ROCK Biology to Translation
2026-08-12
Y-27632 offers a reversible, selective way to interrogate ROCK-dependent cytoskeletal behavior while opening a carefully bounded research bridge to the LPS/TLR4/YAP1 stemness axis described in hepatocytes. This thought-leadership perspective translates that mechanistic opportunity into experimental design, product-selection criteria, and translational strategy.
-
Z-IETD-FMK: Reliable Caspase-8 Assays
2026-08-12
Learn how Z-IETD-FMK (SKU B3232) can help researchers distinguish caspase-8-dependent apoptosis from general metabolic decline, optimize T-cell assays, and interpret complex cell-death phenotypes. This scenario-based guide links formulation, controls, pathway biology, and vendor-selection considerations to practical laboratory decisions.
-
Bafilomycin C1 in High-Content Cell Assays
2026-08-11
Bafilomycin C1 turns lysosomal acidification into a controllable experimental variable for autophagy, toxicity, and high-content phenotyping workflows. This guide pairs V-ATPase inhibition with iPSC-cardiomyocyte imaging, practical dose-finding, and troubleshooting strategies that help distinguish organelle stress from direct electrophysiological injury.
-
Chlorambucil Workflows for Cancer Drug Response
2026-08-11
Build more informative Chlorambucil experiments by separating growth inhibition from actual cell killing. This workflow covers solvent handling, time-resolved viability and apoptosis measurements, model-specific interpretation, and troubleshooting for leukemia, glioma, and comparative cell studies.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-08-09
The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) supports HRP-based immunoblotting when low-abundance protein bands are difficult to visualize. It is intended for research use with nitrocellulose or PVDF membranes and should not be used for diagnostic, clinical, or medical applications.
-
MG-262: Mapping Proteostasis in Inflamed Lung Cells
2026-08-08
MG-262, or Z-Leu-Leu-Leu-B(OH)2, enables reversible interrogation of proteasome function at the intersection of inflammation, ubiquitin signaling, and epithelial cell fate. This article translates cytokine and glucocorticoid findings into a mechanistically controlled proteasome inhibition assay strategy.
-
(5Z)-7-Oxozeaenol in Stress-Signaling Assays
2026-08-07
Explore how the TAK1 inhibitor (5Z)-7-Oxozeaenol can clarify the AMPK–SQSTM1 stress-response circuit. This article translates recent mechanistic findings into assay-design decisions while distinguishing metabolic-stress evidence from inflammation applications.
-
Palomid 529 (P529): A Next-Generation PI3K/Akt/mTOR Inhibito
2026-08-07
Explore how Palomid 529 (P529), a potent dual mTORC1/2 inhibitor, is reshaping cancer research through advanced pathway targeting and radiotherapy enhancement. Uniquely, we analyze the translational impact and protocol strategies beyond what existing resources provide.
-
Vincristine Sulfate: Optimized Protocols for Cancer Research
2026-08-06
Vincristine sulfate, a microtubule disrupter from APExBIO, empowers cancer research with proven anti-proliferative effects and versatile protocol adaptability. This guide details stepwise workflows, troubleshooting strategies, and novel assay insights for maximizing reproducibility and translational value in oncology labs.